Your browser doesn't support javascript.
loading
Cyclic RGD-Functionalized closo-Dodecaborate Albumin Conjugates as Integrin Targeting Boron Carriers for Neutron Capture Therapy.
Kawai, Kazuki; Nishimura, Kai; Okada, Satoshi; Sato, Shinichi; Suzuki, Minoru; Takata, Takushi; Nakamura, Hiroyuki.
Afiliación
  • Kawai K; School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Kanagawa 226-8503, Japan.
  • Nishimura K; School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Kanagawa 226-8503, Japan.
  • Okada S; School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Kanagawa 226-8503, Japan.
  • Sato S; Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama, Kanagawa 226-8503, Japan.
  • Suzuki M; School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Kanagawa 226-8503, Japan.
  • Takata T; Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama, Kanagawa 226-8503, Japan.
  • Nakamura H; Institute for Integrated Radiation and Nuclear Science, Kyoto University, Osaka 590-0494, Japan.
Mol Pharm ; 17(10): 3740-3747, 2020 10 05.
Article en En | MEDLINE | ID: mdl-32845640
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Boro / Portadores de Fármacos / Terapia por Captura de Neutrón de Boro / Integrina alfaVbeta3 / Isótopos / Neoplasias Límite: Animals / Female / Humans Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Boro / Portadores de Fármacos / Terapia por Captura de Neutrón de Boro / Integrina alfaVbeta3 / Isótopos / Neoplasias Límite: Animals / Female / Humans Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Japón